Immutep Limited (IMMP)
USD 1.7
(-2.86%)
USD 1.7
(-2.86%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | -37.7 Million AUD | -2711.31% |
| 2023 | 1.44 Million AUD | 176.27% |
| 2022 | -1.89 Million AUD | -199.74% |
| 2021 | 1.89 Million AUD | 112.67% |
| 2020 | -14.98 Million AUD | 8.91% |
| 2019 | -16.45 Million AUD | -123.54% |
| 2018 | -7.35 Million AUD | -392.05% |
| 2017 | 2.51 Million AUD | 136.6% |
| 2016 | -6.88 Million AUD | -467.42% |
| 2015 | 1.87 Million AUD | -22.79% |
| 2014 | 2.42 Million AUD | -20.86% |
| 2013 | 3.06 Million AUD | 118.59% |
| 2012 | 1.4 Million AUD | 0.0% |
| 2011 | - AUD | -100.0% |
| 2010 | 523.73 Thousand AUD | 0.0% |
| 2009 | - AUD | 0.0% |
| 2008 | - AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q4 | -19.37 Million AUD | 0.0% |
| 2024 FY | -2.26 Million AUD | -256.65% |
| 2024 Q2 | 1.11 Million AUD | 0.0% |
| 2023 Q2 | 750.33 Thousand AUD | 0.0% |
| 2023 FY | 1.44 Million AUD | 176.27% |
| 2023 Q4 | 896.16 Thousand AUD | 0.0% |
| 2022 Q2 | 1.13 Million AUD | 0.0% |
| 2022 FY | -1.89 Million AUD | -199.74% |
| 2022 Q4 | -946.33 Thousand AUD | 0.0% |
| 2021 Q4 | 633.02 Thousand USD | 0.0% |
| 2021 Q2 | 1.15 Million AUD | 0.0% |
| 2021 FY | 1.89 Million AUD | 112.67% |
| 2020 Q2 | -4.53 Million AUD | 0.0% |
| 2020 Q4 | -10.45 Million AUD | 0.0% |
| 2020 FY | -14.98 Million AUD | 8.91% |
| 2019 FY | -16.45 Million AUD | -123.54% |
| 2019 Q4 | -8.86 Million USD | 0.0% |
| 2019 Q2 | -5.3 Million AUD | 0.0% |
| 2018 Q4 | -2.72 Million AUD | 0.0% |
| 2018 FY | -7.35 Million AUD | -392.05% |
| 2018 Q2 | -410.09 Thousand AUD | 0.0% |
| 2017 Q4 | -2.28 Million AUD | 0.0% |
| 2017 Q3 | - AUD | 100.0% |
| 2017 FY | 2.51 Million AUD | 136.6% |
| 2017 Q2 | -1.11 Million AUD | 0.0% |
| 2016 Q2 | -2.74 Million AUD | 0.0% |
| 2016 Q3 | - AUD | 100.0% |
| 2016 FY | -6.88 Million AUD | -467.42% |
| 2016 Q4 | -3.04 Million AUD | 0.0% |
| 2015 FY | 1.87 Million AUD | -22.79% |
| 2015 Q4 | -3.89 Million AUD | 0.0% |
| 2015 Q2 | -3.72 Million AUD | 0.0% |
| 2014 FY | 2.42 Million AUD | -20.86% |
| 2014 Q4 | -5.53 Million AUD | 0.0% |
| 2014 Q2 | -4.37 Million AUD | 0.0% |
| 2013 Q4 | -6.56 Million AUD | 0.0% |
| 2013 FY | 3.06 Million AUD | 118.59% |
| 2013 Q2 | -5.79 Million AUD | 0.0% |
| 2012 FY | 1.4 Million AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2011 FY | - AUD | -100.0% |
| 2010 FY | 523.73 Thousand AUD | 0.0% |
| 2009 FY | - AUD | 0.0% |
| 2008 FY | - AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Tiziana Life Sciences Ltd | -51 Thousand USD | -73831.073% |
| Akari Therapeutics, Plc | -4000.00 USD | -942521.175% |
| SciSparc Ltd. | 2.19 Million USD | 1816.978% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 131.297% |
| Apollomics, Inc. | 127 Thousand USD | 29788.856% |
| 89bio, Inc. | -273 Thousand USD | -13711.299% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 1625.894% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 61.59% |
| Immunovant, Inc. | -231 Thousand USD | -16222.445% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 124.359% |
| Alector, Inc. | -95.05 Million USD | 60.333% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 102.484% |
| Atai Life Sciences N.V. | -5000.00 USD | -753996.94% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -11946.277% |
| Roivant Sciences Ltd. | 109.23 Million USD | 134.517% |
| BioLineRx Ltd. | 1.1 Million USD | 3502.965% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 101.98% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -3839.9% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 115.419% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 61.109% |
| Celularity Inc. | 6.75 Million USD | 658.177% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 139.916% |
| Clene Inc. | 533 Thousand USD | 7174.08% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -66821.385% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -3716.28% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 107.923% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 51.41% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -1043777.27% |
| Generation Bio Co. | -73.91 Million USD | 48.986% |
| ImmunityBio, Inc. | -17.89 Million USD | -110.759% |
| Innoviva, Inc. | 261.06 Million USD | 114.443% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 1648.454% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -5578.441% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 117.641% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -5714.575% |
| Ainos, Inc. | -253.73 Thousand USD | -14760.049% |
| Korro Bio, Inc. | -3.63 Million USD | -938.701% |
| Alkermes plc | 1.37 Billion USD | 102.743% |
| MiMedx Group, Inc. | 266.84 Million USD | 114.13% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -7845.473% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 24.054% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -35580.007% |
| MacroGenics, Inc. | 50.52 Million USD | 174.623% |
| BioAtla, Inc. | -103.73 Million USD | 63.651% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -12023.745% |
| MediciNova, Inc. | 979.7 Thousand USD | 3948.592% |
| Benitec Biopharma Inc. | 108 Thousand USD | 35011.895% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 4801.352% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -2544.099% |
| Avid Bioservices, Inc. | 7.31 Million USD | 615.234% |
| Celularity Inc. | 6.75 Million USD | 658.177% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 698337.907% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 32.135% |
| Arcellx, Inc. | 108.27 Million USD | 134.822% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 17.22% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 139.805% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 13.248% |
| Agenus Inc. | 139.61 Million USD | 127.006% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 170.924% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 402.607% |
| Allakos Inc. | -6.14 Million USD | -513.985% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Annexon, Inc. | -3.26 Million USD | -1054.112% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -148.565% |
| Organovo Holdings, Inc. | -5.38 Million USD | -599.663% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 14.135% |
| Aptorum Group Limited | -1.11 Million USD | -3282.547% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 219.098% |
| Aridis Pharmaceuticals, Inc. | - USD | Infinity% |
| Ardelyx, Inc. | 106.66 Million USD | 135.35% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 169.032% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 115.662% |
| CorMedix Inc. | -205.56 Thousand USD | -18242.323% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 649.874% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 111.539% |
| Pyxis Oncology, Inc. | -2 Million USD | -1785.242% |
| BeiGene, Ltd. | 2.07 Billion USD | 101.814% |
| bluebird bio, Inc. | -4.03 Million USD | -835.604% |
| Bionomics Limited | -434.44 Thousand USD | -8578.774% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 29.742% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | -21082.498% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -125582.823% |
| Prime Medicine, Inc. | -147.9 Million USD | 74.507% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 104.322% |
| PolyPid Ltd. | -1.82 Million USD | -1969.421% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 25960.663% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 31520.706% |
| Precision BioSciences, Inc. | 40.47 Million USD | 193.163% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 1996.622% |
| CalciMedica, Inc. | -58 Thousand USD | -64908.357% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 288.035% |
| Elevation Oncology, Inc. | -39 Thousand USD | -96579.095% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -3122.636% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 160.442% |
| ChromaDex Corporation | 50.78 Million USD | 174.251% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -4415.551% |
| Summit Therapeutics Inc. | -2.05 Million USD | -1739.261% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -12062.854% |
| Compugen Ltd. | 31.45 Million USD | 219.869% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 279.027% |
| Chimerix, Inc. | 324 Thousand USD | 11737.298% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 721.533% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -20.974% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 138.071% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 9792.763% |
| Daré Bioscience, Inc. | 2.76 Million USD | 1461.421% |
| Dyadic International, Inc. | 922.95 Thousand USD | 4185.222% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 45.352% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -1432.095% |
| Eloxx Pharmaceuticals, Inc. | - USD | Infinity% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -232.969% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -9140.705% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -31720.853% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -22343.361% |
| Evogene Ltd. | 1.39 Million USD | 2795.128% |
| Exelixis, Inc. | 1.75 Billion USD | 102.145% |
| Eyenovia, Inc. | - USD | Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 191.105% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | -16152.089% |
| Fortress Biotech, Inc. | 57.85 Million USD | 165.174% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -8528.111% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 105.539% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 50.631% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 50.082% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 110.415% |
| Fortrea Holdings Inc. | 424 Million USD | 108.893% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -121528.539% |
| Gritstone bio, Inc. | -6.26 Million USD | -502.314% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -31584.745% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 327.453% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 160.874% |
| Humacyte, Inc. | -76.55 Million USD | 50.745% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -1789.02% |
| ImmuCell Corporation | 4.39 Million USD | 957.653% |
| Better Therapeutics, Inc. | -2.72 Million USD | -1281.636% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -182.267% |
| Incyte Corporation | 3.44 Billion USD | 101.096% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 99.461% |
| INmune Bio, Inc. | 155 Thousand USD | 24425.708% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -1311.359% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -25549.556% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 104.843% |
| Verastem, Inc. | -62 Thousand USD | -60714.269% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 101.109% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -3302.965% |
| Kodiak Sciences Inc. | -25.94 Million USD | -45.315% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -68454.267% |
| Kura Oncology, Inc. | -849 Thousand USD | -4341.089% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 46.201% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -753996.94% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| ContextLogic Inc. | 59 Million USD | 163.907% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 1247.09% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -7054.62% |
| Mesoblast Limited | -9.81 Million USD | -284.155% |
| Mustang Bio, Inc. | -2.22 Million USD | -1594.6% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -29588.856% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 130.015% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 9479.315% |
| Genelux Corporation | -848 Thousand USD | -4346.326% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -430.631% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 126.893% |
| Molecular Templates, Inc. | 50.39 Million USD | 174.819% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -3034.235% |
| Neurogene Inc. | -3.26 Million USD | -1055.881% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -38770.976% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 90.545% |
| NextCure, Inc. | -3.68 Million USD | -923.476% |
| Omeros Corporation | -69.77 Million USD | 45.965% |
| Onconetix, Inc. | -1.12 Million USD | -3245.104% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -30.16% |
| Opthea Limited | 21.72 Thousand USD | 173695.06% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -65672.681% |
| Precigen, Inc. | 106 Thousand USD | 35670.61% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 7421.33% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -260.986% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 55.283% |
| Pulmatrix, Inc. | -8.22 Million USD | -358.696% |
| Pluri Inc. | 322 Thousand USD | 11809.58% |
| Autolus Therapeutics plc | -4.86 Million USD | -674.704% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -431.204% |
| Purple Biotech Ltd. | -196 Thousand USD | -19137.167% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 100.334% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -7196.592% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 90.566% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 146.051% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -2403.158% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 87.467% |
| Sesen Bio, Inc. | 40 Million USD | 194.262% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -314107.058% |
| Soligenix, Inc. | 97.31 Thousand USD | 38846.747% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -22.161% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | 228.305% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -1225.768% |
| Surrozen, Inc. | -27.23 Million USD | -38.468% |
| Seer, Inc. | 7.02 Million USD | 636.571% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 16.812% |
| Shattuck Labs, Inc. | -2.38 Million USD | -1480.916% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -10957.14% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 324.394% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -685.845% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -856.479% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 16394.863% |
| TG Therapeutics, Inc. | 219.1 Million USD | 117.208% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 1345.618% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -334.038% |
| Blueprint Medicines Corporation | 236.58 Million USD | 115.937% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 2124.965% |
| Calithera Biosciences, Inc. | -1.38 Million USD | -2622.372% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -12812.619% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -39776.101% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 7701.784% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 8992.653% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -45881.521% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 66.071% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -91.405% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 1584.451% |
| Xencor, Inc. | -85.26 Million USD | 55.777% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 151.367% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | 324861.817% |
| Zai Lab Limited | 170.9 Million USD | 122.062% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -2614.532% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| Insmed Incorporated | 239.63 Million USD | 115.734% |
| Century Therapeutics, Inc. | -10.8 Million USD | -248.828% |
| GeoVax Labs, Inc. | -20.72 Million USD | -81.966% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 961.235% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 65.875% |
| XOMA Corporation | 3.86 Million USD | 1076.557% |
| Humacyte, Inc. | -76.55 Million USD | 50.745% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -362446.606% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -3029.345% |
| Immunome, Inc. | -8.9 Million USD | -323.317% |
| Immunic, Inc. | -111 Thousand USD | -33868.331% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 6291.272% |
| Rallybio Corporation | -150 Thousand USD | -25036.565% |
| Jaguar Health, Inc. | 7.72 Million USD | 588.152% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 61.611% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 43.811% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -16437.214% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -129916.714% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 111.153% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 131.486% |
| Trevena, Inc. | 1.45 Million USD | 2691.398% |
| Curis, Inc. | 9.81 Million USD | 484.312% |
| CRISPR Therapeutics AG | 240.95 Million USD | 115.648% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -3302.965% |
| Cytokinetics, Incorporated | -322.59 Million USD | 88.312% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -3410.693% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -128699.778% |
| Erasca, Inc. | -3.73 Million USD | -910.312% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 290037384.615% |
| Fortress Biotech, Inc. | 57.85 Million USD | 165.174% |
| GRI Bio, Inc. | 10.84 Million USD | 447.799% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -56066.074% |
| IGM Biosciences, Inc. | -211.66 Million USD | 82.186% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -121599.203% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -753996.94% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 56.242% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -19849.654% |
| PureTech Health plc | -1.6 Million USD | -2252.143% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -133519.842% |
| MeiraGTx Holdings plc | 287 Thousand USD | 13237.577% |
| Quantum-Si incorporated | 488 Thousand USD | 7826.403% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -961.809% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 109.692% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 66.158% |
| Royalty Pharma plc | 1.79 Billion USD | 102.102% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Cassava Sciences, Inc. | -89.42 Million USD | 57.835% |
| Nutriband Inc. | 862.1 Thousand USD | 4473.579% |
| Solid Biosciences Inc. | -76.56 Million USD | 50.753% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 579.035% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -16962.793% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -16.484% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -921.258% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 337.825% |
| Cue Biopharma, Inc. | -32.6 Million USD | -15.634% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | -47.015% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -16984065.315% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 3836.853% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -21445.627% |
| ProKidney Corp. | -3.16 Million USD | -1089.803% |
| Prothena Corporation plc | -129.2 Million USD | 70.817% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -2080.731% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 1458.447% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 79.215% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -3872.385% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 64.471% |
| Immunocore Holdings plc | 248.39 Million USD | 115.18% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -375035.28% |
| Synaptogenix, Inc. | -6347.00 USD | -593957.775% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -497982.523% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -4179.778% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 52.073% |
| Turnstone Biologics Corp. | 16.5 Million USD | 328.431% |
| 2seventy bio, Inc. | 98.28 Million USD | 138.362% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -14346.302% |
| Vaxxinity, Inc. | -2.23 Million USD | -1587.773% |
| Viridian Therapeutics, Inc. | -1 Million USD | -3640.56% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -71.487% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | -7621.435% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 253.797% |
| Acelyrin, Inc. | -115 Thousand USD | -32686.823% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 66.383% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -74209.907% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Cingulate Inc. | -582.91 Thousand USD | -6368.293% |
| FibroGen, Inc. | 128.9 Million USD | 129.25% |
| MediWound Ltd. | 3.57 Million USD | 1153.797% |
| Senti Biosciences, Inc. | -2.68 Million USD | -1305.324% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -39175.882% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -6685156.56% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 9.661% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 46.205% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -30115.122% |
| Genprex, Inc. | -15 Thousand USD | -251198.634% |
| IO Biotech, Inc. | -756 Thousand USD | -4887.414% |
| OmniAb, Inc. | 14.66 Million USD | 357.073% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -78.257% |
| Veracyte, Inc. | 248.14 Million USD | 115.194% |
| Vor Biopharma Inc. | -3.49 Million USD | -979.749% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -3906.891% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -330412.333% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 84.472% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 123.366% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 354.866% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 147.605% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 19464.817% |
| UroGen Pharma Ltd. | 73.35 Million USD | 151.403% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -41.248% |
| Entera Bio Ltd. | -56 Thousand USD | -67230.084% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 127.874% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 1030.754% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| Novavax, Inc. | 639.93 Million USD | 105.892% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -7081.876% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -85228.25% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | -7563.587% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -56321.577% |
| Histogen Inc. | 3.76 Million USD | 1100.394% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 6643.947% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 19464.817% |
| Portage Biotech Inc. | -54 Thousand USD | -69723.791% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -39776.101% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 29103.728% |
| OncoCyte Corporation | 413 Thousand USD | 9229.503% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -838717.508% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -1904185.202% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 110.611% |
| Amarin Corporation plc | 165.54 Million USD | 122.777% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -6549.885% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -5544.438% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -330412.333% |
| Savara Inc. | -44.26 Million USD | 14.814% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 254.206% |
| Bicycle Therapeutics plc | -129.52 Million USD | 70.889% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | -1248.576% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 166.513% |
| Aura Biosciences, Inc. | -1.29 Million USD | -2811.571% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -223.178% |
| Scopus BioPharma Inc. | - USD | Infinity% |
| Galecto, Inc. | -830 Thousand USD | -4442.753% |
| XBiotech Inc. | -1.74 Million USD | -2061.975% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 18.864% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 174.776% |
| NexImmune, Inc. | -1.02 Million USD | -3578.622% |
| Imunon, Inc. | -720 Thousand USD | -5136.748% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -950.86% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 297.998% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 128.183% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Adagene Inc. | 18.11 Million USD | 308.182% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 229.771% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 123.889% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -9349.836% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -150424.36% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -8528.111% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -36351.64% |
| Psyence Biomedical Ltd. | -240.00 USD | -15710252.917% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -114157.112% |
| ADMA Biologics, Inc. | 88.21 Million USD | 142.741% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -30841.372% |
| Sagimet Biosciences Inc. | 2 Million USD | 1985.242% |
| Biomea Fusion, Inc. | -4.2 Million USD | -797.521% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 256.392% |
| Mereo BioPharma Group plc | 7.42 Million USD | 607.741% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -19303.882% |
| Absci Corporation | -41.84 Million USD | 9.903% |
| aTyr Pharma, Inc. | -2.38 Million USD | -1478.93% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -4410.149% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 105.92% |
| Acasti Pharma Inc. | -11 Thousand USD | -342671.336% |
| Orgenesis Inc. | -5.72 Million USD | -558.6% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 4.164% |
| GH Research PLC | -315 Thousand USD | -11869.793% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -10581.26% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| Replimune Group, Inc. | -2.65 Million USD | -1320.145% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -3665.83% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 121.201% |
| Kronos Bio, Inc. | 1.37 Million USD | 2848.167% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 229.441% |
| MEI Pharma, Inc. | 49.32 Million USD | 176.439% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -9901.286% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 520.438% |
| scPharmaceuticals Inc. | 9.78 Million USD | 485.451% |
| HilleVax, Inc. | -2.15 Million USD | -1648.833% |
| Tharimmune, Inc. | - USD | Infinity% |
| AlloVir, Inc. | -398 Thousand USD | -9373.58% |
| Kineta, Inc. | 5.43 Million USD | 793.997% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -163834.117% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 112.02% |
| OKYO Pharma Limited | -7506.16 USD | -502218.722% |
| Codexis, Inc. | 57.33 Million USD | 165.764% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 1039.568% |
| Cibus, Inc. | 1.42 Million USD | 2751.536% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -9981.51% |
| DBV Technologies S.A. | 15.72 Million USD | 339.731% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -1744.66% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 5991.382% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -133519.842% |
| Moderna, Inc. | 2.15 Billion USD | 101.75% |
| Peak Bio, Inc. | 367.76 Thousand USD | 10352.318% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -4020.748% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 570.957% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -6503.301% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 1564.835% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 121.8% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -6934.486% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -505.992% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 136.22% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | -518.315% |
| Moolec Science SA | -143.3 Thousand USD | -26210.908% |
| Aditxt, Inc. | -111.66 Thousand USD | -33667.551% |
| RenovoRx, Inc. | - USD | Infinity% |
| Geron Corporation | -123.5 Million USD | 69.471% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 7826.403% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -26211.643% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -30554.347% |
| Notable Labs, Ltd. | 113 Thousand USD | 33467.121% |
| Liquidia Corporation | 14.6 Million USD | 358.252% |
| Vericel Corporation | 135.57 Million USD | 127.811% |
| Invivyd, Inc. | -2.02 Million USD | -1759.213% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -18327.035% |
| Vaxcyte, Inc. | -75 Million USD | 49.727% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 134.348% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -9796.285% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -1825.682% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 175.705% |
| PepGen Inc. | -1.18 Million USD | -3084.531% |
| United Therapeutics Corporation | 2.07 Billion USD | 101.821% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | -431.653% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -45556.911% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 57000.952% |
| Belite Bio, Inc | -399 Thousand USD | -9349.836% |
| Pharming Group N.V. | 220.1 Million USD | 117.13% |
| XOMA Corporation | 3.86 Million USD | 1076.557% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 139.126% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| AbCellera Biologics Inc. | 38.02 Million USD | 199.158% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| GeoVax Labs, Inc. | -20.72 Million USD | -81.966% |
| Surrozen, Inc. | -27.23 Million USD | -38.468% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 19.501% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 145.202% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 51671.352% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 78.229% |
| BioVie Inc. | -229.37 Thousand USD | -16337.937% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 74630.237% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -21464.974% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | -64.513% |
| Immix Biopharma, Inc. | -5468.00 USD | -689454.627% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -48239.547% |
| Celcuity Inc. | -142.77 Thousand USD | -26309.133% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 10.901% |
| IN8bio, Inc. | -2.5 Million USD | -1407.591% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 3469.513% |
| Instil Bio, Inc. | -4.75 Million USD | -692.785% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -5714.575% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 77.491% |
| Immuneering Corporation | -764.13 Thousand USD | -4834.298% |
| Verona Pharma plc | -679.62 Thousand USD | -5447.898% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -3410.693% |
| uniQure N.V. | 2.21 Million USD | 1802.25% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -1884.466% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 59.047% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -2899.59% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -689.3% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 3423.243% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -64.672% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -88.186% |
| Zura Bio Limited | - USD | Infinity% |
| Forte Biosciences, Inc. | -9000.00 USD | -418842.744% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -1894.965% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -1466.466% |
| Altimmune, Inc. | -65.37 Million USD | 42.324% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 275.005% |
| Moolec Science SA | -143.3 Thousand USD | -26210.908% |
| Lumos Pharma, Inc. | 2 Million USD | 1978.667% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -21445.627% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -3034.235% |
| Nutriband Inc. | 862.1 Thousand USD | 4473.579% |
| argenx SE | 1.1 Billion USD | 103.401% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -114157.112% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 127.061% |
| NeurAxis, Inc. | 2.15 Million USD | 1848.262% |
| CervoMed Inc. | -1.29 Million USD | -2814.661% |
| AnaptysBio, Inc. | 14.78 Million USD | 355.09% |
| Design Therapeutics, Inc. | -537 Thousand USD | -6921.387% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -8730.175% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 1856.983% |
| Achilles Therapeutics plc | -4.73 Million USD | -696.929% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -3553.57% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 87785.691% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -4486.964% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -286454.545% |
| Palisade Bio, Inc. | 246 Thousand USD | 15427.174% |
| Beam Therapeutics Inc. | -59.67 Million USD | 36.813% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -12595.235% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -836.293% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -294.155% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 367.79% |
| Athira Pharma, Inc. | -969 Thousand USD | -3791.109% |
| Vaccinex, Inc. | -16 Million USD | -135.596% |
| HCW Biologics Inc. | -574.82 Thousand USD | -6459.372% |
| XOMA Corporation | 3.86 Million USD | 1076.557% |
| Nektar Therapeutics | 53.47 Million USD | 170.505% |
| Arvinas, Inc. | 71.8 Million USD | 152.514% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Merus N.V. | -83.46 Million USD | 54.823% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 39.937% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -11609.58% |
| Rezolute, Inc. | -36 Thousand USD | -104635.686% |
| Clene Inc. | 533 Thousand USD | 7174.08% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -2936414.564% |
| BeyondSpring Inc. | 1.75 Million USD | 2253.332% |
| Synlogic, Inc. | -1.92 Million USD | -1859.711% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -101804.992% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -495.465% |
| Peak Bio, Inc. | 367.76 Thousand USD | 10352.318% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -98.834% |
| Krystal Biotech, Inc. | 47.6 Million USD | 179.204% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 126.724% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 850.345% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -1356.225% |
| MannKind Corporation | 136.19 Million USD | 127.685% |
| Ikena Oncology, Inc. | -50.49 Million USD | 25.325% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 134.651% |
| Gossamer Bio, Inc. | -4.38 Million USD | -759.86% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -14862.241% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -753996.94% |
| Legend Biotech Corporation | 140.92 Million USD | 126.754% |
| Mural Oncology plc | -2.56 Million USD | -1368.829% |
| Biora Therapeutics, Inc. | -551 Thousand USD | -6742.985% |
| PaxMedica, Inc. Common Stock | - USD | Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | -37604.847% |
| Champions Oncology, Inc. | 20.75 Million USD | 281.675% |
| REGENXBIO Inc. | 53.02 Million USD | 171.102% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -603.849% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -19499.661% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -2076.954% |
| Vaxart, Inc. | -60.76 Million USD | 37.948% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -14248.446% |
| Cellectis S.A. | 18 Thousand USD | 209571.372% |
| Longeveron Inc. | 221 Thousand USD | 17161.017% |
| Repare Therapeutics Inc. | -80.07 Million USD | 52.91% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 103.45% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -2813.821% |
| Revolution Medicines, Inc. | -399.66 Million USD | 90.566% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -107628.134% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 77048.667% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 100.438% |
| Denali Therapeutics Inc. | -93.34 Million USD | 59.607% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -150424.36% |
| Veru Inc. | 7.56 Million USD | 598.351% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -24870.097% |
| Cingulate Inc. | -582.91 Thousand USD | -6368.293% |
| Passage Bio, Inc. | -3.72 Million USD | -913.299% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -312959.175% |
| Exicure, Inc. | -1.42 Million USD | -2549.673% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -9744.608% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 1494.926% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -7254.532% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 155.346% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -25102.595% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 36.316% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 9743.183% |
| OmniAb, Inc. | 14.66 Million USD | 357.073% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 288.59% |
| Lipocine Inc. | -2.85 Million USD | -1222.597% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -1945.841% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -560.909% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -2403.158% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 150.062% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -57907.457% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 144.729% |
| Ocugen, Inc. | -33.53 Million USD | -12.428% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -1092.437% |
| Q32 Bio Inc. | 578 Thousand USD | 6623.33% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -14128.244% |
| Alumis Inc. Common Stock | -1.28 Million USD | -2836.515% |
| Equillium, Inc. | 35.95 Million USD | 204.858% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -2108.837% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 7630.743% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -911966.933% |
| Galera Therapeutics, Inc. | -259 Thousand USD | -14457.856% |
| Evelo Biosciences, Inc. | - USD | Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | 9019.748% |
| Dominari Holdings Inc. | 2.03 Million USD | 1949.183% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -20450.848% |
| vTv Therapeutics Inc. | -13.59 Million USD | -177.343% |
| Bio-Techne Corporation | 773.07 Million USD | 104.877% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 317.708% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 108.183% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -3125.393% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -57.235% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 422.346% |
| Nkarta, Inc. | -5.86 Million USD | -542.441% |
| BioCardia, Inc. | -7.24 Million USD | -420.139% |
| Iterum Therapeutics plc | -1.75 Million USD | -2054.563% |